Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory DisordersDavid Harrison, Alan P. Watt, Christopher A. Gabel et al.|Journal of Medicinal Chemistry|2023Cited by 62
Pharmacological Analysis of NLRP3 Inflammasome Inhibitor Sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl][(1-methyl-1<i>H</i>-pyrazol-4-yl)({[(2<i>S</i>)-oxolan-2-yl]methyl})sulfamoyl]azanide in Cellular and Mouse Models of Inflammation Provides a Translational FrameworkJohn R. Doedens, Christopher A. Gabel, Beverly H. Koller et al.|ACS Pharmacology & Translational Science|2024Cited by 8
Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an <i>in vivo</i> tool compound for neuroinflammatory disordersDavid Harrison, Alan P. Watt, Andy Billinton et al.|RSC Medicinal Chemistry|2025Cited by 3